Marwa Eid
Cairo, 2011, Egypt
NCT Number: NCT04796064
Sarcopenia is the major health concern and common consequence of COVID-19 in the ageing population. The objective of this study is to find and compare low and high-intensity aerobic training protocols on clinical and psychological effects in community-dwelling older men with post-COVID 19 Sarcopenia.
Looking for future studies?
Notify Me60 year–80 year
Male
Interventional
Not applicable
Cairo, 2011, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A low-intensity aerobic training group started with 15 minutes of warm-up, which includes static stretching of the upper and lower limb muscles. then participants were instructed to do 30 minutes of low-intensity aerobic training exercises, which include 20 minutes on the treadmill and 10 minutes of cycle ergometer, followed by 10 minutes of cool down.
Time frame: 8 weeks
It is a simple and cost-effective test to measure the upper limb strength
Cairo University
Other
Comparative Effectiveness Study of Low Versus High-Intensity Aerobic Training in Community-dwelling Older Men With Post-COVID 19 Sarcopenia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06988176
Atrophy, Elderly (People Aged 65 or More)
Chapel Hill, North Carolina, United States
View Trial DetailsNCT05934760
Aging, Atrophy
Derby, Derbyshire, United Kingdom
View Trial DetailsNCT06496204
Aerobic Fitness, Atrophy
Stockholm, Sweden
View Trial DetailsNCT07761481
Atrophy, Cancer
Querétaro City, Querétaro, Mexico
View Trial Details